Researchers have discovered a new stress signaling system that enables bacteria cells to adapt and protect themselves against the immune system and certain antibiotics.
An enzyme, RlmN, was observed to directly sense chemical and environmental stresses, and rapidly signal for the production of other proteins that allow the bacteria cell to adapt and survive. This breakthrough discovery of RlmN as a stress sensor has revealed a new mechanism of antimicrobial resistance that can be targeted for drug development.
The work was carried out by researchers from the Antimicrobial Resistance (AMR) interdisciplinary research group at the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with MIT, the Singapore Center for Environmental Life Sciences Engineering, and Nanyang Technological University Singapore.
All living cells have sensors that detect environmental changes — such as reactive oxygen species (ROS) or free radicals — caused by cell stress or metabolism. According to the central dogma of molecular biology, this is achieved using a two-step system comprising transcription and translation. This means that genes are transcribed into messenger RNAs, which are subsequently translated on ribosomes by transfer RNAs to produce proteins — the functional building blocks of cells.
SMART AMR’s discovery of the RlmN system illustrates that cells possess a much quicker mechanism for cell responses. This shortcut is the first example of a direct connection between a sensor system and translation machinery to generate proteins to combat ROS.
In an open-access paper titled “An RNA modification enzyme directly senses reactive oxygen species for translational regulation in Enterococcus faecalis,” published July 11 in the scientific journal Nature Communications, the researchers document their discovery of RlmN as a stress sensor for ROS in E. faecalis — a common bacterium found in the human gut that can cause a variety of infections, with catheter-associated urinary tract infections being the most prevalent. They found that when RlmN is suppressed upon contact with ROS, it leads to the selective production of resistance proteins and other pathways associated with antimicrobial resistance known to occur during bacterial responses to stress. RlmN inhibition thus represents a signalling mechanism for bacterial drug resistance and immune evasion, since ROS is induced by certain antibiotics and human immune cells.
The discovery was made using a sophisticated mass spectrometry technology developed at SMART and MIT to simultaneously identify all 50 different ribonucleic acids (RNA) modifications in bacteria. This approach allowed scientists to observe changes in cell behavior or pattern mutations that cannot be detected when studied individually.
Using this tool, the researchers exposed E. faecalis cells to low, nontoxic doses of various antibiotics and toxic chemicals made by the immune system. They found that only one of the 50 modifications changed — a chemical called 2-methyladenosine decreased. As this modification was known to be made by RlmN in other, better-studied bacteria, then researchers proved that this was the case in E. faecalis, too, and went on to show how it is inactivated by ROS.
“This is the first time a direct connection has been found between ROS and RlmN, and it may be a step forward in developing new treatments for bacterial infections,” says MIT Professor Peter Dedon, co-lead principal investigator and co-corresponding author of the paper. “By understanding how RlmN works and the different ways in which bacteria respond to stress, we could uncover other stress sensors that rely on similar mechanisms.”
“Bacteria are incredibly adaptable and can evolve to resist drugs designed to kill them. This growing resistance is a silent pandemic that poses a global threat to public health, as it reduces the efficacy of existing antibiotics and increases mortality rates from infections. Thus, understanding the mechanisms bacteria utilize to adapt against stressors helps researchers develop new and novel therapies to combat AMR,” says Lee Wei Lin, principal research scientist at SMART AMR and first author of the paper. “Moving forward, SMART AMR will work on gaining a comprehensive understanding of this new mechanism of stress response and possible drug resistance.”
As novel, high-impact solutions to combating AMR are a top priority to improve public health, understanding bacterial stress survival mechanisms is an important step forward for the scientific community. By understanding these cell adaptation and survival mechanisms, researchers can design drugs that prevent the adaptation response and ensure that the pathogens retain their sensitivity to antibiotics.
The research is carried out by SMART and supported by the National Research Foundation (NRF) Singapore under its Campus for Research Excellence And Technological Enterprise (CREATE) program.
The AMR interdisciplinary research group is a translational research and entrepreneurship program that tackles the growing threat of antimicrobial resistance. By leveraging talent and convergent technologies across Singapore and MIT, they tackle AMR head-on by developing multiple innovative and disruptive approaches to identify, respond to, and treat drug-resistant microbial infections. Through strong scientific and clinical collaborations, they provide transformative, holistic solutions for Singapore and the world.
